The Pathophysiological Role of PEDF in Bone Diseases
Journal:
Current Molecular Medicine
Volume:
10
Page:
296-301
Author(s):
M.L. Broadhead, T. Akiyama, P.F.M. Choong and C.R. Dass
Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases
Journal:
Current Drug Targets
Volume:
11
Page:
494-505
Author(s):
Junko Morimoto, Shigeyuki Kon, Yutaka Matsui and Toshimitsu Uede
Nutlins and Ionizing Radiation in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1427-1442
Author(s):
Gianna Impicciatore, Silvia Sancilio, Sebastiano Miscia and Roberta Di Pietro
TGF-β Pathway as a Therapeutic Target in Bone Metastases
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1301-1312
Author(s):
Patricia Juarez and Theresa A. Guise
Tubulin-Targeting Agents in Hybrid Drugs
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
609-639
Author(s):
E. C. Breen and J. J. Walsh
Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
196-212
Author(s):
T. Shalaby, E. Hiyama and M.A. Grotzer
The Vitamin D/CYP24A1 Story in Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
213-224
Author(s):
Amanda N. King, David G. Beer, Paul J. Christensen, Robert U. Simpson and Nithya Ramnath
New Medical Strategies for Midgut Carcinoids
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
250-269
Author(s):
Ola Nilsson, Yvonne Arvidsson, Viktor Johanson, Eva Forssell-Aronsson and Hakan Ahlman
Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1040-1054
Author(s):
Kathlynn C. Brown
Understanding FOXO, New Views on Old Transcription Factors
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
135-146
Author(s):
F. Zanella, W. Link and A. Carnero